Therefore, if GC are given early in the course of a viral infection (e.g. within the first week of symptom onset when the innate response is mounting), they are likely to interfere and reduce both the efficacy of IFN production and IFN-mediated reduction of viral spread, enhancing viral replication [28, 31]. Here, IFNA1 is linked to viral infectious disease.